心血管醫療設備市場：按器材類型和地區分類

預計到2026年，心血管醫療設備市場規模將達到712.408億美元，到2033年將達到1426.661億美元。預計從2026年到2033年，該市場將以9.1%的複合年成長率成長。

心血管醫療設備是用於診斷和治療心臟病及相關健康問題的醫療設備。其中包括植入式電子醫療設備，旨在控制或監測患有特定心律不整或心臟衰竭患者的心率。在全球範圍內，越來越多的人使用心電圖 (ECG) 進行診斷和監測。心電圖通常與其他檢查結合使用，以幫助診斷和監測影響心臟的疾病。目前有多種類型的設備可供選擇。

市場動態

心血管疾病的高發生率、老年人口的成長、對心血管醫療設備的需求不斷成長、技術進步、活性化以及市場參與者推出新產品，預計這些因素將推動全球心血管醫療設備市場在預測期內成長。

例如，2022年10月，Medtronic在美國獲得FDA核准，擴大其心臟導線（可連接到心臟的自然電系統）的適應症。這使得患者能夠在接受必要治療的同時，避免傳統心律調節器治療所帶來的併發症。

此外，2022年10月，Biosense Webster公司在歐洲推出了「HELIOSTAR球囊消融導管」。 HELIOSTAR球囊消融導管適用於使用心房導管進行心臟電生理學定位（刺激和記錄），也可與相容的多通道射頻產生器配合使用進行心導管電氣燒灼術。

本次調查的主要特點

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及領先企業採取的競爭策略。
• 本研究根據公司亮點、產品系列、主要特點、財務績效和策略等參數，創建了全球心血管醫療設備市場主要參與者的概況。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
• 這份全球心血管醫療設備市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
• 相關人員可以透過利用分析全球心血管醫療設備市場中使用的各種策略矩陣，更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 全球心血管疾病盛行率正在上升。
  • 心血管醫療設備和心臟治療高成本
  • 全球對心血管醫療設備的需求正在成長。
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景

第4章 全球心血管醫療設備市場：依器材類型分類，2021-2033年

• 診斷和監測設備
• 治療及外科器械

第5章 全球心血管醫療設備市場：依地區分類，2021-2033年

• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第6章 競爭情勢

• Livanova PLC
• B. Braun Melsungen AG
• Edwards Lifesciences
• Biotronik
• Medtronic PLC
• GE Healthcare
• Cardinal Health Inc.
• Abbott Laboratories
• Siemens Healthineers AG
• WL Gore & Associates Inc.
• Boston Scientific Corporation
• Canon Medical Systems Corporation

第7章

• 調查方法
• 關於本公司

Cardiovascular Devices Market is estimated to be valued at USD 71,240.8 Mn in 2026 and is expected to reach USD 142,666.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.

Cardiovascular devices are medical devices used to diagnose and treat heart disease and related health problems. Cardiovascular devices, such as cardiac implantable electronic devices, designed to help control or monitor irregular heartbeats in people with certain heart rhythm disorders and heart failure. More people worldwide are using ECGs for diagnostic and monitoring purposes. An ECG is often used alongside other tests to help diagnose and monitor conditions affecting the heart. There are several types of devices available.

Market Dynamics

High prevalence of cardiovascular diseases, growing geriatric population, increase in demand for cardiovascular devices, technological advances, rise in research and development, and introduction of novel products by market players are major factors expected to propel the growth of the global cardiovascular devices market over the forecast period.

For instance, in October 2022, Medtronic plc received the US FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods.

Moreover, in October 2022, Biosense Webster, Inc. launched the HELIOSTAR Balloon Ablation Catheter in Europe. HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cardiovascular devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Livanova PLC, B. Braun Melsungen AG, Edwards Lifesciences, Biotronik, Medtronic PLC, GE Healthcare, Cardinal Health Inc., Abbott Laboratories, Siemens Healthineers AG, WL Gore & Associates Inc., Boston Scientific Corporation, and Canon Medical Systems Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cardiovascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiovascular devices market.

Market Segmentation

• Global Cardiovascular Devices Market, By Device Type (Revenue, USD Mn, 2021 - 2033)
• Diagnostic and Monitoring Devices
• Therapeutic and Surgical Devices
• Global Cardiovascular Devices Market, By Regional Insights (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Livanova PLC
• Braun Melsungen AG
• Edwards Lifesciences
• Biotronik
• Medtronic PLC
• GE Healthcare
• Cardinal Health Inc.
• Abbott Laboratories
• Siemens Healthineers AG
• WL Gore & Associates Inc.
• Boston Scientific Corporation
• Canon Medical Systems Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Device Type
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increase in prevalence of cardiovascular diseases worldwide
  • High cost of cardiovascular devices and cardiac procedures
  • Increase in demand for cardiovascular devices worldwide
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Cardiovascular Devices Market, By Device Type, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Diagnostic and Monitoring Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Mn)
• Therapeutic and Surgical Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Mn)

5. Global Cardiovascular Devices Market, By Geography, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021-2033,(USD Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021-2033,(USD Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021-2033,(USD Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021-2033,(USD Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021-2033,(USD Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021-2033,(USD Mn)

6. Competitive Landscape

• Livanova PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• B. Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Edwards Lifesciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biotronik
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardinal Health Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• WL Gore & Associates Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Canon Medical Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

7. Section

• Research Methodology
• About us